Prospera Financial Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Sell
18,068
-428
-2% -$38.2K 0.03% 535
2026
Q1
$1.33M Sell
18,496
-1,248
-6% -$96.1K 0.02% 616
2025
Q4
$1.57M Sell
19,744
-2,441
-11% -$192K 0.03% 547
2025
Q3
$1.67M Sell
22,185
-1,543
-7% -$106K 0.03% 522
2025
Q2
$1.64M Buy
23,728
+1,728
+8% +$113K 0.03% 513
2025
Q1
$1.49M Sell
22,000
-5,704
-21% -$341K 0.03% 449
2024
Q4
$1.24M Sell
27,704
-6,851
-20% -$384K 0.03% 487
2024
Q3
$2.17M Buy
34,555
+1,908
+6% +$111K 0.06% 321
2024
Q2
$1.93M Sell
32,647
-718
-2% -$44.9K 0.05% 342
2024
Q1
$2.66M Sell
33,365
-2,749
-8% -$210K 0.08% 283
2023
Q4
$2.85M Sell
36,114
-2,845
-7% -$202K 0.09% 248
2023
Q3
$2.72M Buy
38,959
+5,098
+15% +$361K 0.11% 218
2023
Q2
$2.34M Sell
33,861
-7,130
-17% -$507K 0.09% 247
2023
Q1
$3.05M Buy
40,991
+15,798
+63% +$1.32M 0.13% 198
2022
Q4
$2.35M Sell
25,193
-2,058
-8% -$199K 0.12% 204
2022
Q3
$2.6M Buy
27,251
+308
+1% +$30.5K 0.14% 191
2022
Q2
$2.5M Sell
26,943
-2,197
-8% -$214K 0.13% 201
2022
Q1
$2.95M Sell
29,140
-2,885
-9% -$303K 0.12% 205
2021
Q4
$3.31M Buy
32,025
+1,873
+6% +$173K 0.14% 170
2021
Q3
$2.56M Sell
30,152
-587
-2% -$49.2K 0.13% 197
2021
Q2
$2.57M Sell
30,739
-634
-2% -$51.9K 0.13% 198
2021
Q1
$2.36M Sell
31,373
-343
-1% -$25K 0.14% 182
2020
Q4
$2.17M Buy
31,716
+22,957
+262% +$1.49M 0.15% 173
2020
Q3
$511K Sell
8,759
-15,993
-65% -$995K 0.2% 96
2020
Q2
$1.6M Buy
24,752
+3,031
+14% +$191K 0.14% 184
2020
Q1
$1.29M Sell
21,721
-4,919
-18% -$328K 0.14% 180
2019
Q4
$1.98M Buy
26,640
+4,604
+21% +$323K 0.15% 169
2019
Q3
$1.39M Buy
22,036
+3,309
+18% +$196K 0.14% 149
2019
Q2
$1.03M Buy
18,727
+3,924
+27% +$211K 0.12% 159
2019
Q1
$802K Buy
14,803
+7,391
+100% +$456K 0.26% 110
2018
Q4
$494K Sell
7,412
-1,127
-13% -$84.1K 0.1% 197
2018
Q3
$664K Sell
8,539
-4,094
-32% -$293K 0.12% 173
2018
Q2
$822K Buy
12,633
+44
+0.3% +$2.9K 0.11% 162
2018
Q1
$806K Buy
12,589
+3,329
+36% +$239K 0.11% 173
2017
Q4
$691K Buy
9,260
+12
+0.1% +$872 0.11% 165
2017
Q3
$744K Buy
9,248
+409
+5% +$32.4K 0.11% 168
2017
Q2
$701K Buy
8,839
+5,794
+190% +$457K 0.11% 169
2017
Q1
$238K Sell
3,045
-166
-5% -$13.3K 0.04% 307
2016
Q4
$255K Sell
3,211
-236
-7% -$19.1K 0.05% 296
2016
Q3
$307K Sell
3,447
-324
-9% -$30.6K 0.06% 261
2016
Q2
$361K Buy
3,771
+241
+7% +$24K 0.07% 219
2016
Q1
$355K Sell
3,530
-1,406
-28% -$137K 0.08% 187
2015
Q4
$483K Buy
4,936
+1,590
+48% +$156K 0.11% 132
2015
Q3
$237K Sell
3,346
-4,482
-57% -$471K 0.06% 223
2015
Q2
$721K Sell
7,828
-746
-9% -$76.2K 0.17% 97
2015
Q1
$787K Buy
8,574
+2,085
+32% +$211K 0.18% 84
2014
Q4
$625K Buy
6,489
+2,732
+73% +$241K 0.16% 107
2014
Q3
$223K Buy
+3,757
New +$296K 0.06% 247

Other funds holding CVS

Prospera Financial Services's CVS Position: Q2 2026 in Review

Prospera Financial Services reduced its CVS Health (CVS) stake by 2.3% in Q2 2026, selling an estimated $38.2K and leaving 18,068 shares worth $1.87M. The position accounts for 0.03% of the portfolio, ranked #535.

Prospera Financial Services first reported a position in CVS in Q3 2014 and has held it in 48 quarters since. The position peaked at $3.31M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Prospera Financial Services held 18,068 shares of CVS Health worth $1.87M as of Q2 2026.
  • Prospera Financial Services sold 428 CVS Health shares in Q2 2026, an estimated $38.2K.
  • CVS Health made up 0.03% of Prospera Financial Services's portfolio in Q2 2026, its #535 holding.
  • Prospera Financial Services first reported a position in CVS Health in Q3 2014 and has held it in 48 quarters since.
  • Prospera Financial Services's CVS Health position peaked at $3.31M in Q4 2021.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.